158 related articles for article (PubMed ID: 12151195)
1. Evaluation of in vitro susceptibility testing criteria for gemifloxacin when tested against Haemophilus influenzae strains with reduced susceptibility to ciprofloxacin and ofloxacin.
Biedenbach DJ; Jones RN
Diagn Microbiol Infect Dis; 2002 Aug; 43(4):323-6. PubMed ID: 12151195
[TBL] [Abstract][Full Text] [Related]
2. Activities and postantibiotic effects of gemifloxacin compared to those of 11 other agents against Haemophilus influenzae and Moraxella catarrhalis.
Davies TA; Kelly LM; Hoellman DB; Ednie LM; Clark CL; Bajaksouzian S; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 2000 Mar; 44(3):633-9. PubMed ID: 10681330
[TBL] [Abstract][Full Text] [Related]
3. The in-vitro activity and tentative breakpoint of gemifloxacin, a new fluoroquinolone.
Wise R; Andrews JM
J Antimicrob Chemother; 1999 Nov; 44(5):679-88. PubMed ID: 10552986
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of gemifloxacin against contemporary clinical bacterial isolates from eleven North American medical centers, and assessment of disk diffusion test interpretive criteria.
Fuchs PC; Barry AL; Brown SD
Diagn Microbiol Infect Dis; 2000 Dec; 38(4):243-53. PubMed ID: 11146251
[TBL] [Abstract][Full Text] [Related]
5. Species-independent pharmacodynamics of gemifloxacin and ciprofloxacin with Haemophilus influenzae and Moraxella catarrhalis in an in vitro dynamic model.
Portnoy YA; Vostrov SN; Lubenko IY; Zinner SH; Firsov AA
Int J Antimicrob Agents; 2002 Sep; 20(3):201-5. PubMed ID: 12385699
[TBL] [Abstract][Full Text] [Related]
6. Development of gemifloxacin in vitro susceptibility test methods for gonococci including quality control guidelines. The Quality Control Study Group.
Jones RN; Erwin ME
Diagn Microbiol Infect Dis; 2000 Jul; 37(3):195-201. PubMed ID: 10904193
[TBL] [Abstract][Full Text] [Related]
7. In vitro susceptibility to gemifloxacin and trovafloxacin of Streptococcus pneumoniae strains exhibiting decreased susceptibility to ciprofloxacin.
Fuentes F; Giménez MJ; Marco F; Alou L; Aguilar L; Prieto J
Eur J Clin Microbiol Infect Dis; 2000 Feb; 19(2):137-9. PubMed ID: 10746503
[TBL] [Abstract][Full Text] [Related]
8. Comparative in vitro potency of gemifloxacin against European respiratory tract pathogens isolated in the Alexander Project.
Marchese A; Debbia EA; Schito GC
J Antimicrob Chemother; 2000 Jul; 46 Suppl T1():11-5. PubMed ID: 10997594
[TBL] [Abstract][Full Text] [Related]
9. Comparative in vitro activity of gemifloxacin, ciprofloxacin, levofloxacin and ofloxacin in a North American surveillance study.
Hoban DJ; Bouchillon SK; Johnson JL; Zhanel GG; Butler DL; Miller LA; Poupard JA;
Diagn Microbiol Infect Dis; 2001; 40(1-2):51-7. PubMed ID: 11448564
[TBL] [Abstract][Full Text] [Related]
10. In vitro antibacterial activity of gemifloxacin and comparator compounds against common respiratory pathogens.
Rittenhouse S; McCloskey L; Broskey J; Niconovich N; Jakielaszek C; Poupard J; Coleman K
J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():23-7. PubMed ID: 10824028
[TBL] [Abstract][Full Text] [Related]
11. Differences between two new quinolones (gemifloxacin and trovafloxacin) and ciprofloxacin in their concentration-dependent killing of Streptococcus pneumoniae.
Joyanes P; Pascual A; Giménez MJ; García I; Aguilar L; Perea E
Chemotherapy; 2001 Dec; 47(6):409-14. PubMed ID: 11786655
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial activity of gemifloxacin (SB-265805), a newer fluoroquinolone, against clinical isolates of Neisseria gonorrhoeae, including fluoroquinolone-resistant isolates.
Tanaka M; Tunoe H; Mochida O; Kanayama A; Saika T; Kobayashi I; Naito S
Diagn Microbiol Infect Dis; 2000 Oct; 38(2):109-13. PubMed ID: 11035242
[TBL] [Abstract][Full Text] [Related]
13. Development of in vitro susceptibility testing methods for gemifloxacin (formerly LB20304a or SB-265805), an investigational fluoronaphthyridone.
Jones RN; Erwin ME; Biedenbach DJ; Johnson DM; Pfaller MA
Diagn Microbiol Infect Dis; 1999 Nov; 35(3):227-34. PubMed ID: 10626134
[TBL] [Abstract][Full Text] [Related]
14. Comparative in vitro activity of the new quinolone gemifloxacin (SB-265805) with other fluoroquinolones against respiratory tract pathogens.
García-Garrote F; Cercenado E; Martín-Pedroviejo J; Cuevas O; Bouza E
J Antimicrob Chemother; 2001 May; 47(5):681-4. PubMed ID: 11328784
[TBL] [Abstract][Full Text] [Related]
15. Comparative in vitro potency of gemifloxacin and fluoroquinolones against recent European clinical isolates from a global surveillance study.
Hoban DJ; Bouchillon SK; Johnson JL; Zhanel GG; Butler DL; Miller LA; Poupard JA;
Eur J Clin Microbiol Infect Dis; 2001 Nov; 20(11):814-9. PubMed ID: 11783700
[TBL] [Abstract][Full Text] [Related]
16. Comparative in vitro activity of gemifloxacin against gram-positive and gram-negative clinical isolates in Argentina.
Lopez H; Stepanik D; Vilches V; Scarano S; Sarachian B; Mikaelian G; Finlay J; Sucari A
Diagn Microbiol Infect Dis; 2001 Aug; 40(4):187-92. PubMed ID: 11576792
[TBL] [Abstract][Full Text] [Related]
17. Activity of gatifloxacin against Haemophilus influenzae and Moraxella catarrhalis, including susceptibility test development, E-test comparisons, and quality control guidelines for H. influenzae.
Jones RN; Biedenbach DJ; Erwin ME; Beach ML; Pfaller MA
J Clin Microbiol; 1999 Jun; 37(6):1999-2002. PubMed ID: 10325362
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of quinolones against S. pneumoniae, H. influenzae and M. catarrhalis in Saudi Arabia.
Balkhy HH; Memish ZA; Shibl A; Elbashier A; Osoba A
East Mediterr Health J; 2005; 11(1-2):36-44. PubMed ID: 16532669
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and pharmacodynamics of gemifloxacin versus levofloxacin in guinea pig pneumococcal pneumonia induced by strains with decreased ciprofloxacin susceptibility.
García-Olmos M; Parra A; García-Calvo G; Ponte C; Giménez MJ; Aguilar L; Soriano F
Int J Antimicrob Agents; 2003 Jun; 21(6):568-73. PubMed ID: 12791471
[TBL] [Abstract][Full Text] [Related]
20. Anti-gonococcal activity of gemifloxacin against fluoroquinolone-resistant strains and a comparison of agar dilution and Etest methods.
Jones RN; Deshpande LM; Erwin ME; Barrett MS; Beach ML
J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():67-70. PubMed ID: 10824035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]